No Prescription |
 |
 | ||
|
PARAFON DS Paraflex |
|
| ||
No Prescription » Prescription Drugs 13 » PARAFON DS Paraflex This medication is used to treat pain and discomfort from muscle injuries such as strains sprains and spasms. It provides temporary relief and is usually used along with rest physical therapy and other treatments (e.g. nonsteroidal anti-inflammatory medication). This medication relaxes tight muscles and relieves pain cramping and stiffness so you can move around more and get back to doing your daily activities. Chlorzoxazone belongs to a class of drugs called muscle relaxants. It is thought to work on the nerves to relieve muscle pain. It may also relieve pain by calming your nervous system.How to use Parafon DS OralTake this medication by mouth usually 3 or 4 times daily or as directed by your doctor.The dosage is based on your medical condition and response to therapy. Do not increase your dose take it more often or take it for longer than prescribed. This may increase your risk for side effects.Inform your doctor if your condition does not improve or if it worsens.Parafon Forte DSC Oral is used to treat the following:Muscle Spasm Buy PARAFON DS Paraflex and other Prescription Drugs 13 products online at Medstore. 4055
About PARAFON DS Paraflex: Product Type: Prescription Drugs 13 PARAFON DS ( Paraflex Parafon Forte Relaxazone Remular-S Generic Chlorzoxazone/Acetaminophen ) PARAFON DS (Paraflex Parafon Forte Relaxazone Remular-S Generic Chlorzoxazone/Acetaminophen) Paraflex Parafon Forte Relaxazone Remular-S Generic Chlorzoxazone/Acetaminophen 250/300mg 200 Tablets Paraflex Parafon Forte Relaxazone Remular-S Generic Chlorzoxazone/Acetaminophen PARAFON DS
View more Prescription Drugs 13 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
